Oleg Pohotsky - Tekla Life Independent Trustee
| XHQLX Fund | USD 15.33 0.16 1.05% |
Mr. Oleg M. Pohotsky is Independent Trustee of HQ Life Sciences Investors. Mr. Pohotsky serves as Chairman of the Board of Trustees of each Fund and also serves as Chairman of each Fund Valuation Committee and serves on each Fund Audit Committee. He has over 45 years of cumulative board experience in the full range of organization types publiclytraded, privatelyheld, venturebacked and nonprofit. He has also served as a director of a healthcare services company listed on the Nasdaq NMS where he was a member of the audit committee. In his various directorships he has also served on investment, compensation, personnel and executive committees. His career spanned over twenty years in the investment industry, both as an investment banker and as a VC and private equity investor, and included serving as chairman of the valuation and fairness opinion committee of a NYSEmember firm. Mr. Pohotsky also currently serves on the Board of Directors of Avangardco Investments Holdings, an LSElisted agribusiness enterprise based in Ukraine, on the board of directors of the New America High Income Fund, Inc., a closed end fund investing in high yield securities on a leveraged basis and on the Board of Advisors of Kaufman Co., LLC, a Bostonbased boutique investment banking firm, and is affiliated with GovernanceMetrics International, Inc. as a Senior Advisor. He provides each Fund with valuable experience in valuation and the financial industry
| Age | 69 |
| Tenure | 24 years |
| Professional Marks | MBA |
Similar Money Managers
| Found 10 records | One Year Return | ||
| Gerard OReilly | Vanguard Total Stock | N/A | |
| Gerard OReilly | Vanguard Total Stock | N/A | |
| Gerard OReilly | Vanguard Total Stock | N/A | |
| Michelle Louie | Vanguard 500 Index | N/A | |
| Michelle Louie | Vanguard 500 Index | N/A | |
| Gerard OReilly | Vanguard Total Stock | N/A | |
| Michelle Louie | Vanguard 500 Index | N/A | |
| Michael Perre | Vanguard Total International | N/A | |
| Gerard OReilly | Vanguard Total Stock | N/A | |
| Michael Perre | Vanguard Total International | N/A | |
Tekla Life Sciences Leadership Team
Elected by the shareholders, the Tekla Life's board of directors comprises two types of representatives: Tekla Life inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Tekla. The board's role is to monitor Tekla Life's management team and ensure that shareholders' interests are well served. Tekla Life's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Tekla Life's outside directors are responsible for providing unbiased perspectives on the board's policies.
| William Reardon, Independent Trustee | ||
| Michael Bonney, Independent Trustee | ||
| Oleg Pohotsky, Independent Trustee | ||
| Lucinda Stebbins, Independent Trustee | ||
| Daniel Omstead, President Trustee | ||
| Uwe Reinhardt, Independent Trustee | ||
| Rakesh Jain, Independent Trustee |
Tekla Fund Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right mutual fund is not an easy task. Is Tekla Life a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Tekla Life in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Tekla Life's short interest history, or implied volatility extrapolated from Tekla Life options trading.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Tekla Life Sciences. Also, note that the market value of any mutual fund could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Please note, there is a significant difference between Tekla Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tekla Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tekla Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.